about
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary co...
Read More
11.65
0.01
(0.09%)
1.0M
XNAS Volume
XNAS 31 Dec, 2025 4:30 PM (EST)
Medium Financial Strength
Expensive Valuation
Technically Neutral
Expensive Performer
These stocks have medium quality and momentum.Their expensive valuations suggest caution
View Similar
Embed DVM
ARS Pharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..